tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
US Market

ACADIA Pharmaceuticals (ACAD) Income Statement

Compare
2,282 Followers

ACADIA Pharmaceuticals Income Statement

Last quarter (Q3 2024), ACADIA Pharmaceuticals's total revenue was $250.40M, an increase of 18.28% from the same quarter last year. In Q3, ACADIA Pharmaceuticals's net income was $32.77M. See ACADIA Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 726.44M$ 517.24M$ 484.14M$ 441.75M$ 339.08M
Gross Profit
$ 680.71M$ 507.07M$ 465.00M$ 421.20M$ 319.48M
Operating Expenses
$ 754.09M$ 730.66M$ 635.44M$ 707.79M$ 566.02M
Depreciation and Amortization
$ 5.55M$ 2.03M$ 3.34M$ 2.93M$ 2.77M
EBITDA
$ -67.83M$ -221.57M$ -167.09M$ -286.59M$ -243.78M
Operating Income
$ -73.38M$ -223.60M$ -170.44M$ -286.59M$ -246.54M
Other Income/Expenses
$ 22.34M$ 10.15M$ 2.92M$ 5.61M$ 12.16M
Pretax Income
$ -51.04M$ -213.44M$ -167.52M$ -280.97M$ -234.38M
Net Income
$ -61.29M$ -215.97M$ -167.87M$ -281.58M$ -235.26M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.37$ -1.34$ -1.05$ -1.79$ -1.60
Diluted EPS
$ -0.37$ -1.34$ -1.05$ -1.79$ -1.60
Weighted Average Shares Outstanding
163.82M 161.68M 160.49M 157.33M 147.20M
Weighted Average Shares Outstanding (Diluted)
163.82M 161.68M 160.49M 157.33M 147.20M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis